Soluble ST2 for predicting heart failure, atrial fibrillation and death in patients with coronary heart disease with or without renal insufficiency
Author:
Li Huiying,
Zhu Qiwei,
Bai Jing,
Chen Jianqiao,
Zhu Zifan,
Hao Benchuan,
Wang Wei,
Bai Yongyi,
Liu HongbinORCID
Reference37 articles.
1. 2021 ACC/AHA/SCAI Guideline for coronary artery revascularization: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines;Lawton;J. Am. Coll. Cardiol.,2022
2. Cardiac monocytes and macrophages after myocardial infarction;Peet;Cardiovasc. Res.,2020
3. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction;Weinberg;Circulation,2002
4. Prognosis value of serum soluble ST2 level in acute ischemic stroke and STEMI patients in the era of mechanical reperfusion therapy;Mechtouff;J. Neurol.,2022
5. A review of novel cardiac biomarkers in acute or chronic cardiovascular diseases: the role of soluble ST2 (sST2), lipoprotein-associated phospholipase A2 (Lp-PLA2), myeloperoxidase (MPO), and procalcitonin (PCT);Li;Dis. Markers,2021